MDA 2023: Walking, other functions retained longer on Radicava
Amyotrophic lateral sclerosis (ALS) patients treated with Radicava (edaravone) tend to go longer before reaching disease milestones such…
Articles by Marisa Wexler, MS
Radicava ORS fares well in Phase 3 clinical trial
Note: This story was updated March 10, 2023, to correct a secondary headline to note the therapy was tracked for…
Significant differences between sexes seen in ALS gene study results
The gene expression profiles of motor neurons — the specialized nerve cells that control movement and are lost in…
Screens in diverse cell models in lab ID 2 new ALS therapeutic targets
A team of U.S. researchers have identified two proteins in the lab — PIKFYVE and SYF2 — that may each…
NINDS sets new priorities for ALS research to improve life quality
A group of experts, led by scientists from the National Institute of Neurological Disorders and Stroke (NINDS), has published a…
Motor neurons’ size may make them vulnerable to ALS
Human motor neurons rely on a specialized molecular architecture to help support their large size, which may partially explain why…
Soft wearable robot improves arm function for people with ALS
A wearable robotic device that helps lift the shoulders to support arm movements can make it easier for people with…
ICER releases analysis on cost of ALS therapies
Note: This story were updated Feb. 14, 2023, to correct that ICER analyses found both Radicava ORS and Relyvrio…
Scientists Grow Mature Nerve Cells From Stem Cells
Scientists have developed a new method that allows them to grow mature nerve cells from stem cells — a technique…
Stentrode Device Allows 4 Paralyzed ALS Patients to Use Computers
Synchron‘s Stentrode, an implantable brain-computer interface designed to allow people with amyotrophic lateral sclerosis (ALS) and other…